Analogues of carbacholine: synthesis and relationship between structure and affinity for muscarinic and nicotinic acetylcholine receptors
- PMID: 8851473
- DOI: 10.1002/ardp.19963290207
Analogues of carbacholine: synthesis and relationship between structure and affinity for muscarinic and nicotinic acetylcholine receptors
Abstract
A series of acyclic and heterocyclic analogues of carbacholine (1) was synthesized using N-methylcarbacholine (MCC, 2), N,N-dimethylcarbacholine (DMCC, 3), and the corresponding tertiary amine (4) as leads. Whereas nicotinic acetylcholine receptor affinity was determined using [3H]nicotine as the radioactive ligand, [3H]oxotremorine-M ([3H]Oxo-M) and [3H]quinuclidinyl benzilate ([3H]QNB), in some cases supplemented with [3H]pirenzepine ([3H]PZ), were used as radioligands for muscarinic acetyicholine receptors on rat brain membranes. On the basis of receptor binding data, nicotinic/muscarinic (N/M) selectivity factors were determined, and muscarinic receptor efficacy (M agonist index) and M1 selectivity (M2/M1 index) estimated. In most cases, quaternized analogues showed higher affinity than the corresponding tertiary amines for muscarinic and, in particular, nicotinic receptor sites. Among the new compounds, N,N-diethylcarbacholine (9e) (IC50 = 0.046 microM), (S)-1-methyl-2-(N,N- dimethyl-aminocarbonyloxymethyl)pyrrolidine (17k) (IC50 = 0.068 microM), and the corresponding quaternized analogue, 18k (IC50 = 0.018 microM) showed the highest nicotinic receptor affinity. The tertiary amine, 17k showed much higher nicotinic receptor affinity than the acyclic analogue, 4 (IC50 = 5.7 microM), and the N/M selectivity factor determined for 17k (150) is an order of magnitude lower than that of nicotine (1400). THe N/M selectivity factors for MCC (2) and DMCC (3), previously reported to be highly selective nicotinic receptor ligands, were shown to be 6.5 and 60, respectively, the latter value being comparable with that of 18k (89).
Similar articles
-
Affinity ligands and related agents for brain muscarinic and nicotinic cholinergic receptors.Biochem Pharmacol. 1993 May 25;45(10):2143-8. doi: 10.1016/0006-2952(93)90028-u. Biochem Pharmacol. 1993. PMID: 8512596
-
[3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.J Pharmacol Exp Ther. 1986 May;237(2):411-8. J Pharmacol Exp Ther. 1986. PMID: 3754580
-
6beta-Acetoxynortropane: a potent muscarinic agonist with apparent selectivity toward M2-receptors.J Med Chem. 1998 Jun 4;41(12):2047-55. doi: 10.1021/jm9705115. J Med Chem. 1998. PMID: 9622546
-
A hydrazide linker strategy for heterobivalent compounds as ortho- and allosteric ligands of acetylcholine-binding proteins.Curr Top Med Chem. 2011 Nov;11(22):2731-48. doi: 10.2174/156802611798184427. Curr Top Med Chem. 2011. PMID: 22039876 Review.
-
Strychnine and its mono- and dimeric analogues: a pharmaco-chemical perspective.Nat Prod Rep. 2022 Oct 19;39(10):1910-1937. doi: 10.1039/d1np00079a. Nat Prod Rep. 2022. PMID: 35380133 Review.
Cited by
-
Acetylcholinesterase Inhibitors and Drugs Acting on Muscarinic Receptors- Potential Crosstalk of Cholinergic Mechanisms During Pharmacological Treatment.Curr Neuropharmacol. 2017;15(4):637-653. doi: 10.2174/1570159X14666160607212615. Curr Neuropharmacol. 2017. PMID: 27281175 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources